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Summary 
We compared 4-dimensional computed tomography (4DCT) ventilation imaging, an emerging 
functional imaging modality, with pulmonary function test measurements and single-photon 
emission CT (SPECT) ventilation images, which are the clinical references for global and 
regional lung function, respectively. An 18-patient study demonstrated significant correlations 
between 4D-CT ventilation images and pulmonary function test as well as single-photon 
emission CT ventilation images, providing evidence toward validation of 4D-CT ventilation 
imaging. 
  
Purpose 
4-dimensional computed tomography (4D-CT)-based pulmonary ventilation imaging is an 
emerging functional imaging modality. The purpose of this study was to investigate the 
physiological significance of 4D-CT ventilation imaging by comparison with pulmonary 
function test (PFT) measurements and single-photon emission CT (SPECT) ventilation images, 
which are the clinical references for global and regional lung function, respectively. 
Methods and Materials 
In an institutional review board–approved prospective clinical trial, 4D-CT imaging and PFT 
and/or SPECT ventilation imaging were performed in thoracic cancer patients. Regional 
ventilation (V4DCT) was calculated by deformable image registration of 4D-CT images and 
quantitative analysis for regional volume change. V4DCT defect parameters were compared with 
the PFT measurements (forced expiratory volume in 1 second (FEV1; % predicted) and 
FEV1/forced vital capacity (FVC; %). V4DCT was also compared with SPECT ventilation (VSPECT) 
to (1) test whether V4DCT in VSPECT defect regions is significantly lower than in nondefect regions 
by using the 2-tailed t test; (2) to quantify the spatial overlap between V4DCT and VSPECT defect 
regions with Dice similarity coefficient (DSC); and (3) to test ventral-to-dorsal gradients by 
using the 2-tailed t test. 
Results 
Of 21 patients enrolled in the study, 18 patients for whom 4D-CT and either PFT or SPECT were 
acquired were included in the analysis. V4DCT defect parameters were found to have significant, 
moderate correlations with PFT measurements. For example, V4DCTHU defect volume 
increased significantly with decreasing FEV1/FVC (R=−0.65, P<.01). V4DCT in VSPECT defect 
regions was significantly lower than in nondefect regions (mean V4DCTHU 0.049 vs 
0.076, P<.01). The average DSCs for the spatial overlap with SPECT ventilation defect regions 
were only moderate (V4DCTHU0.39 ± 0.11). Furthermore, ventral-to-dorsal gradients 
of V4DCT were strong (V4DCTHU R
2 = 0.69, P=.08), which was similar 
to VSPECT (R
2 = 0.96, P<.01). 
Conclusions 
An 18-patient study demonstrated significant correlations between 4D-CT ventilation and PFT 
measurements as well as SPECT ventilation, providing evidence toward the validation of 4D-CT 
ventilation imaging. 
 
 
  
Introduction 
Despite technological advances in the field, overall survival of lung cancer remains 
disappointing, and toxicity is substantial. Radiation pneumonitis is a common, potentially fatal 
toxicity that occurs in up to 30% of lung cancer patients treated with radiation therapy 1, 2, 3. 
Radiation therapy that selectively avoids irradiating highly functional lung regions may reduce 
pulmonary toxicity. This hypothesis is supported by several reports in the literature 
demonstrating that pulmonary toxicity correlates more strongly with the functional dose-volume 
parameters than the anatomic parameters (current clinical standard) 4, 5, 6. For example, 
Vinogradskiy et al (6) found that the functional (ventilation) parameters (eg, functional mean 
lung dose) had stronger correlations with grade ≥3 pneumonitis than the anatomic parameters 
(eg, mean lung dose) for 96 non-small cell lung cancer (NSCLC) patients (6). 
 
There have been many modalities for pulmonary ventilation imaging, including single-photon 
emission computed tomography (SPECT) (7), positron emission tomography (PET) (8), 
magnetic resonance (MR) 9, 10, 11, and dual-energy CT (12). Ventilation images can also be 
acquired by an emerging technique based on 4-dimensional (4D) or biphasic (exhalation and 
inhalation) CT, deformable image registration (DIR) and quantitative analysis 13, 14, 15. 
Compared to other modalities, 4D-CT ventilation imaging has a higher resolution (the exact 
spatial resolution is unknown), lower cost, shorter scan time, and/or greater availability. 4D-CT 
ventilation can be considered “free” information for lung cancer patients treated with radiation 
therapy 14, 16, as 4D-CT scans are currently in routine use for radiation therapy at most centers 
(17) and ventilation computation involves only image processing and analysis. Prior to clinical 
applications, 4D-CT ventilation imaging should be validated against ground truth. Animal 
studies have demonstrated strong correlations between 4D-CT ventilation and xenon CT 
ventilation 15, 18, and also high reproducibility (19). However, human studies have reported 
inconsistent results 19, 20, 21, 22; for example, reasonable correlations have been found with 
hyperpolarized 3He MR ventilation (21), whereas weak correlations have been found with 
technetium-99m-labeled diethylenetriamine pentaacetate (99mTc-DTPA) SPECT ventilation 
images (20). Also, only poor-to-moderate reproducibility has been demonstrated 19, 22. These 
results suggest the need for further validation. The purpose of this study was to investigate the 
physiological significance of 4D-CT ventilation imaging by comparison with (1) pulmonary 
function test (PFT) measurements as the clinical reference for global lung function; and (2) 
99mTc-DTPA SPECT ventilation images as the clinical reference for regional ventilation for 
patients with thoracic cancer. 
 
Methods and Materials 
Study design 
This study was a prospective, single-arm, single-institutional clinical trial approved by the 
institutional review board. All patients provided written informed consent. Patients were eligible 
for participation if they had a primary or metastatic thoracic cancer to be treated with radiation 
therapy and were ≥18 years of age. We performed 4D-CT imaging (standard of care) as well as 
PFT and/or SPECT ventilation imaging with an attempt to acquire all the data prior to treatment 
(Supplementary Fig. S1). 
 
4D-CT ventilation imaging 
The first step of 4D-CT ventilation imaging was acquiring 4D-CT scans in the supine posture, 
using a Discovery ST multislice PET/CT scanner (GE Healthcare, Waukesha, WI). Scan 
parameters were 120 kVp, approximately 100 mAs per slice, 0.5-second gantry rotation, 0.45-
second cine interval, and 2.5-mm slice thickness. CT data segments were then sorted into 10 
respiratory bins by the phase-based method using Advantage 4D software (GE Healthcare) and 
anatomic similarity-based method designed to reduce artifacts (23). The resulting 4D-CT image 
with fewer 4D-CT artifacts was identified qualitatively and quantitatively by using the 
normalized cross correlation-based artifact score (24) and was selected for ventilation 
computation and subsequent analysis. 
 
The second step was DIR for spatial mapping of the peak inhalation 4D-CT image (moving) to 
the peak exhalation image (fixed). We used a volumetric elastic DIR method that minimizes both 
a similarity function (sum of squared difference between the peak exhalation and deformed peak 
inhalation 4D-CT images) and a regularization term (elastic regularization) based on the Navier-
Lamé equation. Further details of the algorithm have been described elsewhere (25). The 
registration accuracy was previously studied by quantifying the target registration error for 
anatomic landmarks in the lung, which were found to be less than the voxel dimension on 
average 25, 26, 27. The algorithm was evaluated in the MICCAI EMPIRE10 Challenge and 
placed 8th among 34 participants (27). Note that the accuracy for the cohort of patients used in 
this study has not been evaluated. 
The final step was to quantify regional volume change per lung voxel volume, yielding a 4D-CT 
ventilation image at the peak exhalation phase (V4DCT). We investigated 2 different metrics: 
Hounsfield unit (HU) change-based metric (𝑉4𝐷𝐶𝑇
𝐻𝑈 ) and a Jacobian-based metric 
(𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
).  𝑉4𝐷𝐶𝑇
𝐻𝑈 was defined based on the relationship between the regional HU change and 
regional volume change 13, 28 as well as CT density scaling, expressed as 
 
 
where HU is the HU value, u is the displacement vector mapping the voxel at location (x,y,z) of a 
peak exhalation image to the corresponding location of a peak inhalation image, and ρscaling is 
the CT density scaling factor ρscaling=(HUex+1024)/774, which takes a value ranging from 0 for 
the voxel with the lowest lung CT density (−1024 HU) to 1 for the voxel with the highest density 
(−250 HU), in a manner similar to that in Kipritidis et al (29). The rationale for density scaling is 
to transform a purely mechanical model of regional ventilation based on volume change alone to 
a more physiological model. Gas transport to high alveolar density regions contributes more to 
gas exchange and, hence, is considered more physiologically relevant than gas transport to low 
alveolar density regions. It was assumed that alveolar density was proportional to CT density. In 
the same manner as that described by Guerrero et al (14), mass correction was applied to HUin to 
account for the differences in lung mass between the peak exhalation and peak inhalation 
phases. 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐  was defined by 
 
The detailed derivation of the equations for 𝑉4𝐷𝐶𝑇
𝐻𝑈  and 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
, is described in the Appendix. For 
both 𝑉4𝐷𝐶𝑇
𝐻𝑈  and 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
, a value <0 indicated regional contraction, and a value >0 indicated 
regional expansion. The lung parenchyma was segmented by delineating lung voxels with less 
than (or equal to) −250 HU (14) within the lung outlines generated by the model-based 
segmentation of a Pinnacle3 radiation therapy treatment planning system (Philips Radiation 
Oncology Systems, Fitchburg, WI). 
Comparison of 4D-CT ventilation defect parameters with PFT measurements 
PFTs were performed to measure forced expiratory volume in 1 second (FEV1 [% predicted]), 
forced vital capacity (FVC [% predicted]), FEV1/FVC (%), and diffusing capacity of the lung for 
carbon monoxide (DLco [% predicted]) with an HDpft system (nSpire Health, Longmont, CO) 
according to American Thoracic Society (ATS)/European Respiratory Society (ERS) 
guidelines (30). FEV1 and FEV1/FVC were chosen to analyze correlation with V4DCT defect 
parameters, using the Pearson correlation, given that these parameters have been found to 
correlate significantly with hyperpolarized gas MR ventilation defect parameters 31, 32. We 
investigated the following V4DCT defect parameters: (1) the lowest 25th percentile V4DCT value; (2) 
the absolute defect volume (l); and (3) the percentage defect volume. Given that no data are 
available on 4D-CT ventilation threshold values to identify defect regions, the threshold was 
determined by finding a value which gave the average percentage of defect volume of 
approximately 25%. Mathew et al 21, 33 found the average percentage defect volume of 25% for 
a similar cohort of patients by using hyperpolarized 3He MR ventilation imaging. The threshold 
was found to be 0.015, yielding the mean volume of 1.1 ± 1.4 l (25% ± 21% of the total lung 
volume) for 𝑉4𝐷𝐶𝑇
𝐻𝑈  and 1.2 ± 1.5 l (25 ± 20%) for 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
. 
Comparison of 4D-CT ventilation with SPECT ventilation images 
V4DCT was compared with VSPECT to (1) test whether V4DCT in VSPECT defect regions was significantly 
lower than in nondefect regions; (2) quantify the spatial overlap between V4DCTand VSPECT defect 
regions; and (3) test ventral-to-dorsal gradients. VSPECT scans and low-dose CT scans for 
attenuation correction were acquired in the supine posture with an Infinia Hawkeye (GE 
Healthcare) SPECT/CT scanner. 99mTc-DTPA was aerosolized using an Insta/Vent system 
(Medi/Nuclear, Baldwin Park, CA) and was then administered to the patient in the supine posture 
through slow, moderately deep breathing. SPECT projections were acquired in a 64 × 64 matrix 
with an 8.8- × 8.8-mm2 pixel size, 8.8-mm slice spacing, 60 projections over 360°, and 
30 seconds per projection during tidal breathing. SPECT images were reconstructed using the 3D 
ordered subsets expectation maximization (OSEM) algorithm (34) with attenuation correction. 
The low-dose CT image of SPECT was rigidly aligned with the peak exhalation 4D-CT image, 
using the Pinnacle3 system. Central airways (plus a 1-cm margin) which were manually 
delineated using the Pinnacle3 system, were excluded from all comparisons of V4DCT and VSPECT, 
considering central airway depositions of 99mTc-DTPA aerosols observed frequently in patients 
with chronic obstructive pulmonary disease (COPD) (7). 
VSPECT defect regions were segmented by delineating lung voxels with a value less than a 
threshold, which was determined as the mean intensity of the background noise plus twice the 
standard deviation of the distribution of the background noise in a manner similar to that used by 
Kauczor et al (35), yielding the mean volume of 24% ± 11% of the total lung 
volume. V4DCT defect regions were segmented by the method described earlier. The 2-tailed t test 
was used to examine whether V4DCT in VSPECT defect regions is significantly lower than in 
nondefect regions (P<.05). The Dice similarity coefficient (DSC) (36) was used to quantify the 
spatial overlap between V4DCT and VSPECT defect regions. Furthermore, ventral-to-dorsal gradient 
was evaluated to determine whether 4D-CT ventilation imaging shows the known effect of 
gravity on ventilation (ie, greater ventilation in the dorsal region than in the ventral region due to 
the lung parenchyma tissue shift toward gravity-dependent region). This effect has been 
demonstrated with other imaging modalities 11, 37, 38. We quantified the slope (regression 
coefficient) from linear regression for the relationship between the relative ventral-to-dorsal 
distance and globally normalized ventilation value at the corresponding distance. The total lung 
was divided into 5 coronal section regions of interest, equally spaced along the ventral-to-dorsal 
direction. The mean ventilation value was quantified for each region of interest. Statistical 
analysis was performed to test whether the slope was significantly different from zero (P<.05), 
using the 2-tailed t test. 
Results 
Patients 
Between January 2010 and December 2012, 21 patients met the eligibility criteria and were 
enrolled in the study. Of 21 patients, 4D-CT images were acquired as standard of care for all 
patients. FEV1, FEV1/FVC, and SPECT data were acquired for 16, 15, and 16 patients, 
respectively. Data for the other patients were not available because of withdrawal from the 
clinical trial or incorrect data acquisition. Eighteen patients, for whom PFT and/or SPECT data 
was available, were included in the analysis. Characteristics of 18 patients are shown in Table 1. 
Several patients received repeat 4D-CT scans, and the one acquired closest to the SPECT scan 
time was selected for the analysis. Compared to 4D-CT, the average interval was 56 ± 53 days, 
and the differences in dose delivered prior to the measurement was 1 ± 3 Gy for PFT, 
9 ± 10 days, and 4 ± 13 Gy for SPECT. Variable intervals and the dose differences were mainly 
due to logistical reasons, such as patient availability, machine availability, and patient no-show. 
 
Figure 1 shows the relationship between FEV1/FVC and 𝑉4𝐷𝐶𝑇
𝐻𝑈  defect parameters for 15 patients. 
FEV1/FVC decreased significantly with decreasing lowest 25th percentile 𝑉4𝐷𝐶𝑇
𝐻𝑈 value 
(R=0.73, P<.01) and with increasing defect volume (R=−0.65, P<.01) and %defect volume 
(R=−0.63, P=.01). Table 2 shows correlations between V4DCT defect parameters and PFT 
measurements. In general, both 𝑉4𝐷𝐶𝑇
𝐻𝑈  and 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
, demonstrated significant, moderate correlations 
with FEV1 and FEV1/FVC, indicating that severe V4DCT defect is correlated with impaired global 
lung function. 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
, had slightly stronger correlations, especially with FEV1, than 𝑉4𝐷𝐶𝑇
𝐻𝑈 . 
4D-CT ventilation versus SPECT ventilation 
Figure 2a shows a comparison between 𝑉4𝐷𝐶𝑇
𝐻𝑈  and VSPECT for patient 16, showing a good 
correlation and large separation between the probability density functions 
of 𝑉4𝐷𝐶𝑇
𝐻𝑈  in VSPECT defect regions and nondefect regions. The mean 𝑉4𝐷𝐶𝑇
𝐻𝑈  value 
in VSPECT nondefect regions (0.06 ± 0.06) was higher than in defect regions (0.02 ± 0.04), 
showing a clear separation between the peaks of the 2 probability density functions. The DSC 
for 𝑉4𝐷𝐶𝑇
𝐻𝑈 and VSPECT defect regions was 0.46. In contrast, patient 18 showed a poor correlation 
and small separation between the probability density functions of 𝑉4𝐷𝐶𝑇
𝐻𝑈  in VSPECT defect regions 
and nondefect regions (Fig. 2b). The mean 𝑉4𝐷𝐶𝑇
𝐻𝑈  value in VSPECT nondefect regions (0.11 ± 0.08) 
was only slightly higher than in defect regions (0.09 ± 0.08). The DSC was 0.35. 
High VSPECT values were noted along the border between the left lung and mediastinum due to 
image registration errors, resulting in erroneous defect regions along the left chest wall. Both 
patient 16 and 18 showed nonsevere central airway depositions in VSPECT. V4DCT values 
in VSPECT defect regions and nondefect regions for 16 patients are summarized in Table 3. 
Both 𝑉4𝐷𝐶𝑇
𝐻𝑈  and 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 demonstrated significantly higher values in nondefect regions than in 
defect regions, whether or not 6 patients with severe central airway depositions in VSPECT were 
excluded from the analysis. The average DSCs for the spatial overlap with VSPECT regions were 
found to be only moderate (0.39 ± 0.11 for 𝑉4𝐷𝐶𝑇
𝐻𝑈 ; 0.36 ± 0.13 for 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
). 
Figure 3 shows ventral-to-dorsal gradients of V4DCT and VSPECT for 16 patients. 
Both 𝑉4𝐷𝐶𝑇
𝐻𝑈 and 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 demonstrated strong, but statistically nonsignificant ventral-to-dorsal 
gradients (𝑉4𝐷𝐶𝑇
𝐻𝑈  R2=0.69, P=.08; 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 R2=0.68, P=.09), indicating higher ventilation in dorsal 
regions than in ventral regions. VSPECT showed a strong, significant gradient (R
2=0.96, P<.01). 
For 6 patients with severe central airway depositions in VSPECT, the ventral-to-dorsal gradient was 
still strong, but statistically nonsignificant (R2=0.74, P=.06). 
Discussion 
This study demonstrated significant moderate correlations between V4DCT defect parameters and 
PFT measurements (FEV1 and FEV1/FVC), significantly lower V4DCT in VSPECT defect regions 
than in nondefect regions, moderate DSCs between V4DCT and VSPECT defect regions, and 
moreover strong ventral-to-dorsal gradients. These results provide evidence toward the 
validation of 4D-CT ventilation imaging. PFT and SPECT ventilation imaging are widely 
accepted clinical standard methods for the evaluation of global and regional lung function, 
respectively. This is the first investigation to compare 4D-CT ventilation imaging with PFT in a 
cohort of thoracic cancer patients. Murphy et al (39) compared biphasic (end-expiration and end-
inspiration) breath-hold CT-based ventilation with PFT measurements for 126 COPD patients 
and found strong correlations (0.73-0.88). There are several major differences from our study, 
including CT image quality, breathing maneuver and patient characteristics, which might have 
led to stronger correlations compared to our study. Other modalities including hyperpolarized 
gas MR 32, 33, 40 were found to correlate significantly with PFT. Stavngaard et al (41) reported 
the correlation of 0.5 (P<.05) between FEV1 and 
81mKr SPECT ventilated volume, which was 
similar to our study (FEV1 vs VSPECT defect volume R=−0.54, P=.04). Several investigators 
compared 4D-CT ventilation imaging with other modalities, including 99mTc-DTPA SPECT 
ventilation (20) and hyperpolarized 3He MR ventilation (21) for lung cancer patients. Reasonable 
overlaps of defect regions were observed for MR ventilation (21). Overall only poor overlaps of 
percentile lung regions were reported for SPECT ventilation, whereas the overlap was relatively 
better in poorly ventilated regions than in well-ventilated regions (20). We found moderate DSCs 
between V4DCT and VSPECT defect regions, which were consistent with data from Castillo et al 
(20). Only moderate DSCs may be, at least in part, the result of spatial resolution difference. 
High resolution 4D-CT ventilation images provide more details and detect smaller defect regions 
compared to low resolution SPECT ventilation images. V4DCT demonstrated significantly higher 
values in VSPECT nondefect regions than in defect regions. However, it is unknown whether or 
not this is clinically significant. Proving clinical significance would ultimately require clinical 
trials to test a clinically relevant hypothesis. 
There are several limitations in this study, including 4D-CT artifacts and limited quality of 
SPECT ventilation images. The current clinical standard 4D-CT technique with phase-based 
sorting often results in artifacts (42). In this study, we used phase-based sorting and anatomic 
similarity-based sorting to use the image with fewer artifacts for the analysis, though there were 
residual artifacts. Recently Yamamoto et al (24) demonstrated that 4D-CT artifacts are an 
important source of variations in 4D-CT ventilation imaging. Future developments of strategies 
to improve 4D-CT may increase the correlation with PFT and SPECT ventilation. Even though 
99mTc-DTPA SPECT ventilation imaging is a widely accepted clinical standard method for 
evaluating regional lung function, it provides images of limited quality due to low resolution and 
central airway depositions observed frequently in patients with COPD (7). Considering these 
limitations, SPECT ventilation imaging does not necessarily provide a ground truth. For future 
studies, comparisons with high-quality ventilation images such as xenon CT with dual-energy 
CT 12, 43 may provide a better understanding on the physiological significance of 4D-CT 
ventilation imaging. 
There are several major differences between 4D-CT and PFT or SPECT, including the time, dose 
delivered prior to the measurement, breathing maneuver, and posture. All the measurements 
should ideally be acquired on the same day to minimize possible effects of time and dose 
differences on lung function. We consider that such effects on the results of this study would be 
limited for the following reasons. A subgroup analysis by dividing the patients by the median 
interval into 2 groups did not result in significant differences in the results between the 2 groups 
(data not shown). Recently Yuan et al (44) observed nonsignificant PFT changes during a course 
of treatment (at approximately 45 Gy) for 56 stage I-III NSCLC patients who received ≥60 Gy, 
whereas they observed a significant improvement in SPECT ventilation. Given that the dose 
difference in our patient cohort (PFT 1 ± 3 Gy; SPECT 4 ± 13 Gy) was considerably smaller than 
45 Gy (44), the effect of dose difference on global and regional lung function is assumed to be 
minimal. Tumor growth over the interval period between the measurements (56 ± 53 days for 
PFT; 9 ± 10 days for SPECT) might affect lung function. A long interval between 4D-CT and 
PFT was due to the fact that several patients received PFT as part of the standard of care rather 
than specifically for the study. However, the effect is considered small because the intervals were 
much shorter than the tumor volume doubling time of 139 days (median) reported by Wang et al 
(45). SPECT provides respiration-averaged ventilation images, which may be better compared 
with 4D-CT ventilation images averaged over a respiratory cycle. Differences in positioning (eg, 
arm position, immobilization) between the 4D-CT and SPECT scans affected the quality of 
image registration. DIR algorithms optimized and validated to allow accurate registration to low-
dose CT images of SPECT may increase the correlations. Given these limitations, the 
correlations between 4D-CT ventilation and PFT or SPECT ventilation found in this study would 
represent lower bounds to the true correlation. 
Conclusions 
An 18-patient study demonstrated significant correlations between 4D-CT ventilation images and 
PFT as well as SPECT ventilation images, providing evidence toward the validation of 4D-CT 
ventilation imaging. Further studies are needed to explore the physiological and clinical 
significance of 4D-CT ventilation imaging. 
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Table 1. Patient characteristics 
Parameter Value 
Age (y) 67 ± 12 
Sex 
 Male 15 (83.3) 
 Female 3 (16.7) 
FEV1 (%pred)∗ 67 ± 29 
FVC (%pred)† 80 ± 24 
FEV1/FVC (%)‡ 69 ± 24 
DLCO (%pred)§ 79 ± 25 
Histology 
 Lung cancer 14 (77.8) 
 Thoracic paraganglioma 1 (5.6) 
 Metastases to the lung 3 (16.6) 
Clinical stage‖ 
 I 3 (20.0) 
 II 2 (13.3) 
 III 6 (40.0) 
 IV 4 (26.7) 
Lung volume (l)¶ 
 Peak exhalation 3.6 ± 1.7 
 Peak inhalation 4.2 ± 1.8 
Abbreviations: DLco = diffusing capacity of the lung for carbon monoxide; FEV1 = forced expiratory 
volume in 1 second; FVC = forced vital capacity. 
Data are means ± SD or numbers with percentages in parentheses. 
∗ Available for 16 patients. 
† Available for 14 patients. 
‡ Available for 15 patients. 
§ Available for 13 patients. 
‖ For 15 patients with primary lung cancer or thoracic paraganglioma. 
¶ Determined by the segmentation method for the 4D-CT images (see Methods and Materials). 
 
 
 
  
Table 2. Correlations between 4D-CT ventilation defect parameters and pulmonary function test (PFT) 
measurements 
PFT 
parameter 
𝑉4𝐷𝐶𝑇
𝐻𝑈  𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 
25th 
Percentile 
Defect 
volume 
% Defect 
volume 
25th 
Percentile 
Defect 
volume 
% Defect 
volume 
FEV1(%pred)∗ 0.45 (0.08) −0.56 (0.03) −0.43 (0.10) 0.68 (<0.01) −0.66 
(<0.01) 
−0.68 (<0.01) 
FEV1/FVC 
(%)† 
0.73 (<0.01) −0.65 
(<0.01) 
−0.63 (0.01) 0.73 (<0.01) −0.64 (0.01) −0.64 (0.01) 
Abbreviations: 𝑉4𝐷𝐶𝑇
𝐻𝑈  = 4D-CT ventilation with Hounsfield unit (HU)-change metric,  
𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 = 4D-CT ventilation with Jacobian metric, FEV1 = forced expiratory volume in 1 s, FVC = forced 
vital capacity. 
Data are Pearson correlation coefficients (R). Values in parentheses are P values. 
∗ Available for 16 patients. 
† Available for 15 patients. 
 
  
Table 3. 4D-CT ventilation in SPECT defect regions versus in SPECT nondefect regions 
Central airway depositions 
in VSPECT 
𝑉4𝐷𝐶𝑇
𝐻𝑈  𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 
VSPECT 
defect 
VSPECT 
nondefect 
P 
Value 
VSPECT 
defect 
VSPECT 
nondefect 
P 
Value 
None or nonsevere (n=10) 0.056 
(0.041) 
0.093 (0.058) <.01 0.071 
(0.046) 
0.088 (0.051) .03 
Severe (n=6) 0.037 
(0.028) 
0.047 (0.027) .05 0.023 
(0.007) 
0.030 (0.007) .02 
All (n=16) 0.049 
(0.036) 
0.076 (0.053) <.01 0.053 
(0.043) 
0.067 (0.050) <.01 
Abbreviations: 
𝑉4𝐷𝐶𝑇
𝐻𝑈  = 4D-CT ventilation with Hounsfield unit (HU)-change metric,  
𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 = 4D-CT ventilation with Jacobian metric, VSPECT = SPECT ventilation. 
Data are mean V4DCT values in VSPECT defect regions and nondefect regions. Values in parentheses are 
±SD. 
 
 
 
  
 
 
 
Fig. 1. FEV1/FVC (%) versus 𝑉4𝐷𝐶𝑇
𝐻𝑈  defect parameters: (a) 25th percentile value, (b) absolute defect volume (l), and 
(c) % of defect volume for 15 patients. The lines of best fit are also shown. 
 
  
 
 
 
Fig. 2. Comparison of 𝑉4𝐷𝐶𝑇
𝐻𝑈  and VSPECT for (a) patient 16, showing a large separation between 
the probability density functions of 𝑉4𝐷𝐶𝑇
𝐻𝑈  in VSPECT defect regions and nondefect regions, and (b) 
patient 18, showing a small separation. Orange outlines in VSPECT denote defect regions. 
Both 𝑉4𝐷𝐶𝑇
𝐻𝑈  and VSPECT are shown with a scale from zero to the 90th percentile value. 
 
 
  
 
 
 
Fig. 3. Ventral-to-dorsal gradients of (a) 𝑉4𝐷𝐶𝑇
𝐻𝑈
 (y=0.02x+0.99), (b) 𝑉4𝐷𝐶𝑇
𝐽𝑎𝑐
 (y=0.02x+0.99) and 
(c) VSPECT(y=0.73x+0.56) for all 16 patients for whom VSPECT was available. Each data point (error bar) represents the 
mean value (±SD) of globally normalized ventilation in a coronal section region of interest. 
